I-Ciforadenant
Iinkcukacha zeMveliso
Iithegi zeMveliso
Ubungakanani bePakethi | Ubukho | Ixabiso (USD) |
100mg | Ikhona evenkileni | 750 |
1g | Ikhona evenkileni | 2900 |
Iisayizi ezininzi | Fumana iiQuotes | Fumana iiQuotes |
Igama leMchiza:
(S) -7-(5-methylfuran-2-yl)-3-((6-((((tetrahydrofuran-3-yl)oxy)methyl)pyridin-2-yl)methyl)-3H-[1,2 ,3] i-triazolo[4,5-d] pyrimidin-5-amine
Ikhowudi yoncumo:
NC1=NC2=C(N=NN2CC3=NC(CO[C@H]4CCOC4)=CC=C3)C(C5=CC=C(O5)C)=N1
Ikhowudi ye-InChi:
InChI=1S/C20H21N7O3/c1-12-5-6-16(30-12)17-18-19(24-20(21)23-17)27(26-25-18)9-13- 3-2-4-14(22-13)10-29-15-7-8-28-11-15/h2-6,15H,7-11H2,1H3,(H2,21,23,24)/ t15-/m0/s1
Isitshixo se-InChi:
KURQKNMKCGYWRJ-HNNXBMFYSA-N
Igama elingundoqo:
Ciforadenant, CPI-444, V81444, CPI444, CPI 444
Ukunyibilika:Inyibilika kwi-DMSO
Ugcino:0 - 4°C ixesha elifutshane (iintsuku ukuya kwiiveki), okanye -20°C ixesha elide (iinyanga)
Inkcazo:
I-CPI-444 inamandla, ifumaneka ngomlomo, i-antagonist ekhethiweyo ye-adenosine A2A receptor eye yanyamezelwa kakuhle kwizifundo ze-Ph 1 / 1b kwizibonakaliso ezingekho kwi-oncology.
Ithagethi: Adenosine A2A